This inventor holds 4 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Comprehensive Biomarker Center Gmbh, Hummingbird Diagnostics Gmbh. Active years: 2016-2019.
Company Filing History:
2 out of 7 
2 out of 13 Years Active: 2016-2019
Title: Anke Wendschlag: Innovator in Biomedical Research
Introduction
Anke Wendschlag is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of biomedical research, particularly in the areas of multiple sclerosis and kidney cancer. With a total of 4 patents, her work has the potential to impact patient care and treatment outcomes.
Latest Patents
One of her latest patents focuses on "MiRNA based treatment monitoring in multiple sclerosis." This invention relates to methods for determining patient responses to therapeutic treatments for multiple sclerosis, monitoring the disease's progression, assessing relapse risks, and adjusting drug dosages based on miRNA levels in patient samples. Additionally, it includes a kit designed for these purposes, enhancing the management of multiple sclerosis.
Another significant patent involves "Complex sets of miRNAs as non-invasive biomarkers for kidney cancer." This invention provides non-invasive methods and kits for diagnosing and prognosing kidney cancer using body fluid samples. It includes sets of polynucleotides and primer pairs for detecting miRNAs, which can aid in early diagnosis and treatment planning for kidney cancer patients.
Career Highlights
Anke has worked with notable companies such as Hummingbird Diagnostics GmbH and Comprehensive Biomarker Center GmbH. Her experience in these organizations has allowed her to develop innovative solutions in the biomedical field.
Collaborations
Throughout her career, Anke has collaborated with esteemed colleagues, including Andreas Keller and Markus Beier. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Anke Wendschlag is a trailblazer in biomedical innovation, with her patents paving the way for improved diagnostic and therapeutic strategies in multiple sclerosis and kidney cancer. Her work exemplifies the impact of scientific research on healthcare advancements.